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to be a worthy undertaking. Another unanswered ques-
tion is why only partial resistance to camptothecin was
seen when small interfering RNA to topoisomerase 1
was introduced into TERT/LT/ST/RASV12 cells. Perhaps
there are other as yet unknown targets for the campto-
thecins that exist. We also do not know how important
the transfected gene expression stoichiometry is for the
ultimate sensitivity to particular agents. Nonetheless,
Dolma et al. [5] nicely illustrate the power of the synthetic
lethal approach for exposing agents with both unique
and potentially rich pharmacological properties. ItFigure 1. A Schematic Representation of the Traditional Synthetic
Lethal Strategy Used in Yeast Genetics Studies seems likely that many others will emulate their ap-
proach.(A) A and B represent different genes. When both normal genes are
present, the yeast are viable, signified by the smiling face. When
either gene A or B are altered or deleted (indicated with ), the
John S. Lazoorganism remains viable; when both genes are mutated, the lethal
phenotype, signified by the frowning face, occurs. Department of Pharmacology
(B) In a synthetic lethal chemical screen, the lethal phenotype occurs University of Pittsburgh
only when the organism has the altered gene or genes and is ex- Pittsburgh, Pennsylvania 15232
posed to a specific chemical agent. Thus, the concentration/dose-
response curve is shifted to the left in the cells that have the altered
or deleted gene(s). In some cases, the small molecule might inhibit
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Novel Carotenoids
Genetically Engineered tures are targets for modification and for mixing
substituents in the same molecule.in a Heterologous Host
Compounds can be synthesized in a modular way by
combining genes that comprise different branches of a
biosynthetic pathway, which are isolated from different
Carotenoids are commercially important pigments that organisms. Pioneering work following this approach was
are essential for human health. Diverse carotenoids carried out on the synthesis of novel polyketide antibiot-
have been identified, but availability has impeded eval- ics [1]. This strategy only works, however, when the
uation of their pharmaceutical potential. Molecular substrate specificity of a key biosynthetic enzyme is
techniques have been developed to produce specific such that it does not need to recognize the entire sub-
and novel carotenoids with improved biological activ- strate molecule but only certain regions of the molecule
ities. that are suitable for conversion. This is generally also
the case in carotenoid biosynthesis, and therefore this
Over the last few years, molecular procedures have been combinatorial approach was very successful in generat-
developed to engineer metabolic pathways. These in- ing numerous carotenoids including novel structures not
clude directed evolution by gene shuffling to alter the found before [2]. Among the carotenoids produced by
catalytic properties of enzymes, and combinatorial bio- combinatorial biosynthesis were carotenoids with im-
synthesis, i.e., coexpression of genes encoding different proved biological activity [3].
enzymes from related pathways. Both approaches have Highly homologous carotenogenic genes from related
successfully been applied to carotenoid biosynthesis. organisms may encode enzymes with modified sub-
The color of carotenoids is very helpful for the screening strate and/or product specificities [4], but this is a rare
and selection of transformants. Typical carotenoids occurrence. One experimental way of acquiring en-
zymes with extended catalytic properties for the synthe-consist of 40 carbon atoms with an extensive conju-
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sis of novel carotenoids is gene shuffling. Stemmer first Researchers have made tremendous advances in this
described this technique in 1994 [5], and it involves the field, from generating the first heterologous carotenoid
recombination of two or more DNA segments modified by expressing a gene cluster from Erwinia in noncaro-
by mutagenesis or originating from different organisms tenogenic E. coli in 1990 [8, 9], to the first combination
into a full-length gene. The library of reassembled genes of carotenogenic genes from different organisms in 1993
is then screened for functional diversity. By random [10], and, finally, to Lee and colleagues’ detailed and
shuffling of phytoene desaturase genes from two Erwinia systematic exploitation of combinatorial biosynthesis
species, a recombined gene was obtained encoding an using genes mutated by gene shuffling for the provision
enzyme which introduced six instead of four double bonds of special precursors [7]. When gene shuffling and com-
into the phytoene molecule, yielding 3,4,3,4-tetradehy- binatorial biosynthesis are complementary, there is a
drolycopene [6]. In addition, a lycopene cyclase was huge potential for the creation of unique and diverse
generated with several altered amino acids, which, un- carotenoids, provided that appropriate wild-type genes
like the nonmodified enzyme, was able to convert 3,4- are available. In the future, mutagenesis by error-prone
didehydrolycopene into the corresponding monocyclic PCR, which has already been used to generate a type
product torulene. of phytoene synthase able to form C30 and C40 products
In the May issue of Chemistry & Biology, Lee et al. [7] [11], will most likely be employed to extend the potential
presented an extensive study on the generation of novel of combinatorial biosynthesis of carotenoids.
carotenoids by using the genes of the modified desatur-
ase and cyclase mentioned above and coexpressing
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